Ensuring safe and effective drugs: who can do what it takes?
Identifieur interne : 001F70 ( Istex/Corpus ); précédent : 001F69; suivant : 001F71Ensuring safe and effective drugs: who can do what it takes?
Auteurs : Tom Jefferson ; Peter Doshi ; Matthew Thompson ; Carl Heneghan ; Cochrane Acute Respiratory Infections GroupSource :
- BMJ [ 0959-8138 ] ; 2011.
English descriptors
- Teeft :
- Absolute measures, Acute influenza, Adverse events, Analysis plan, Case histories, Clinical study reports, Cochrane, Cochrane collaboration, Cochrane review, Cochrane reviews, Critical overview, Drug companies, Drug industry, Effective drugs, Evidence base, Full trial programme, Healthy adults, Important outcomes, Independent investigators, Influenza, Inhibitor, Myocardial infarction, Neuraminidase, Neuraminidase inhibitors, Oseltamivir, Patient privacy, Policy makers, Primary publication, Programme, Protocol, Regulator, Regulatory documents, Respiratory infections group, Roche, Same studies, Scientific press, Separate reports, Single trials, Study protocol, Study reports, Sufficient detail, Systematic review, Systematic reviews, Target audience, Test hypothesis, Trial programme, Unpublished, Unpublished data, Unpublished material, Unpublished trials, Whole trial programme, Wrong conclusions.
Abstract
Drawing on their experience in producing a Cochrane review of neuraminidase inhibitors for influenza, Tom Jefferson and colleagues discuss how to improve the reliability of systematic reviews
Url:
DOI: 10.1136/bmj.c7258
Links to Exploration step
ISTEX:575369706032E9792BDE8E219ABA64598CDB13EALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Ensuring safe and effective drugs: who can do what it takes?</title><author><name sortKey="Jefferson, Tom" sort="Jefferson, Tom" uniqKey="Jefferson T" first="Tom" last="Jefferson">Tom Jefferson</name><affiliation><mods:affiliation>Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author><author><name sortKey="Doshi, Peter" sort="Doshi, Peter" uniqKey="Doshi P" first="Peter" last="Doshi">Peter Doshi</name><affiliation><mods:affiliation>Program in History, Anthropology, Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author><author><name sortKey="Thompson, Matthew" sort="Thompson, Matthew" uniqKey="Thompson M" first="Matthew" last="Thompson">Matthew Thompson</name><affiliation><mods:affiliation>Department of Primary Health Care, University of Oxford, Oxford, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Family Medicine, Oregon Health and Sciences University, Portland, Oregon, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author><author><name sortKey="Heneghan, Carl" sort="Heneghan, Carl" uniqKey="Heneghan C" first="Carl" last="Heneghan">Carl Heneghan</name><affiliation><mods:affiliation>Department of Primary Health Care, University of Oxford, Oxford, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author><author><name sortKey="Group, Cochrane Acute Respiratory Infections" sort="Group, Cochrane Acute Respiratory Infections" uniqKey="Group C" first="Cochrane Acute Respiratory Infections" last="Group">Cochrane Acute Respiratory Infections Group</name><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:575369706032E9792BDE8E219ABA64598CDB13EA</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1136/bmj.c7258</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-7VL246DW-T/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001F70</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001F70</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Ensuring safe and effective drugs: who can do what it takes?</title><author><name sortKey="Jefferson, Tom" sort="Jefferson, Tom" uniqKey="Jefferson T" first="Tom" last="Jefferson">Tom Jefferson</name><affiliation><mods:affiliation>Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author><author><name sortKey="Doshi, Peter" sort="Doshi, Peter" uniqKey="Doshi P" first="Peter" last="Doshi">Peter Doshi</name><affiliation><mods:affiliation>Program in History, Anthropology, Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author><author><name sortKey="Thompson, Matthew" sort="Thompson, Matthew" uniqKey="Thompson M" first="Matthew" last="Thompson">Matthew Thompson</name><affiliation><mods:affiliation>Department of Primary Health Care, University of Oxford, Oxford, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Family Medicine, Oregon Health and Sciences University, Portland, Oregon, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author><author><name sortKey="Heneghan, Carl" sort="Heneghan, Carl" uniqKey="Heneghan C" first="Carl" last="Heneghan">Carl Heneghan</name><affiliation><mods:affiliation>Department of Primary Health Care, University of Oxford, Oxford, UK</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author><author><name sortKey="Group, Cochrane Acute Respiratory Infections" sort="Group, Cochrane Acute Respiratory Infections" uniqKey="Group C" first="Cochrane Acute Respiratory Infections" last="Group">Cochrane Acute Respiratory Infections Group</name><affiliation><mods:affiliation>E-mail: pnd@mit.edu</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="ISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2011">2011</date><biblScope unit="volume">342</biblScope></imprint><idno type="ISSN">0959-8138</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0959-8138</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Absolute measures</term><term>Acute influenza</term><term>Adverse events</term><term>Analysis plan</term><term>Case histories</term><term>Clinical study reports</term><term>Cochrane</term><term>Cochrane collaboration</term><term>Cochrane review</term><term>Cochrane reviews</term><term>Critical overview</term><term>Drug companies</term><term>Drug industry</term><term>Effective drugs</term><term>Evidence base</term><term>Full trial programme</term><term>Healthy adults</term><term>Important outcomes</term><term>Independent investigators</term><term>Influenza</term><term>Inhibitor</term><term>Myocardial infarction</term><term>Neuraminidase</term><term>Neuraminidase inhibitors</term><term>Oseltamivir</term><term>Patient privacy</term><term>Policy makers</term><term>Primary publication</term><term>Programme</term><term>Protocol</term><term>Regulator</term><term>Regulatory documents</term><term>Respiratory infections group</term><term>Roche</term><term>Same studies</term><term>Scientific press</term><term>Separate reports</term><term>Single trials</term><term>Study protocol</term><term>Study reports</term><term>Sufficient detail</term><term>Systematic review</term><term>Systematic reviews</term><term>Target audience</term><term>Test hypothesis</term><term>Trial programme</term><term>Unpublished</term><term>Unpublished data</term><term>Unpublished material</term><term>Unpublished trials</term><term>Whole trial programme</term><term>Wrong conclusions</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Drawing on their experience in producing a Cochrane review of neuraminidase inhibitors for influenza, Tom Jefferson and colleagues discuss how to improve the reliability of systematic reviews</div></front></TEI><istex><corpusName>bmj</corpusName><keywords><teeft><json:string>cochrane</json:string><json:string>neuraminidase</json:string><json:string>oseltamivir</json:string><json:string>roche</json:string><json:string>neuraminidase inhibitors</json:string><json:string>programme</json:string><json:string>evidence base</json:string><json:string>systematic reviews</json:string><json:string>healthy adults</json:string><json:string>study protocol</json:string><json:string>regulator</json:string><json:string>cochrane review</json:string><json:string>systematic review</json:string><json:string>cochrane reviews</json:string><json:string>study reports</json:string><json:string>policy makers</json:string><json:string>absolute measures</json:string><json:string>analysis plan</json:string><json:string>trial programme</json:string><json:string>whole trial programme</json:string><json:string>target audience</json:string><json:string>inhibitor</json:string><json:string>influenza</json:string><json:string>adverse events</json:string><json:string>cochrane collaboration</json:string><json:string>primary publication</json:string><json:string>wrong conclusions</json:string><json:string>unpublished trials</json:string><json:string>effective drugs</json:string><json:string>clinical study reports</json:string><json:string>sufficient detail</json:string><json:string>drug industry</json:string><json:string>single trials</json:string><json:string>respiratory infections group</json:string><json:string>independent investigators</json:string><json:string>drug companies</json:string><json:string>regulatory documents</json:string><json:string>full trial programme</json:string><json:string>critical overview</json:string><json:string>unpublished material</json:string><json:string>same studies</json:string><json:string>myocardial infarction</json:string><json:string>patient privacy</json:string><json:string>unpublished data</json:string><json:string>acute influenza</json:string><json:string>case histories</json:string><json:string>test hypothesis</json:string><json:string>important outcomes</json:string><json:string>separate reports</json:string><json:string>scientific press</json:string><json:string>protocol</json:string><json:string>unpublished</json:string></teeft></keywords><author><json:item><name>Tom Jefferson</name><affiliations><json:string>Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy</json:string><json:string>E-mail: pnd@mit.edu</json:string></affiliations></json:item><json:item><name>Peter Doshi</name><affiliations><json:string>Program in History, Anthropology, Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA, USA</json:string><json:string>E-mail: pnd@mit.edu</json:string><json:string>E-mail: pnd@mit.edu</json:string></affiliations></json:item><json:item><name>Matthew Thompson</name><affiliations><json:string>Department of Primary Health Care, University of Oxford, Oxford, UK</json:string><json:string>Department of Family Medicine, Oregon Health and Sciences University, Portland, Oregon, USA</json:string><json:string>E-mail: pnd@mit.edu</json:string></affiliations></json:item><json:item><name>Carl Heneghan</name><affiliations><json:string>Department of Primary Health Care, University of Oxford, Oxford, UK</json:string><json:string>E-mail: pnd@mit.edu</json:string></affiliations></json:item><json:item><name>Cochrane Acute Respiratory Infections Group</name><affiliations><json:string>E-mail: pnd@mit.edu</json:string></affiliations></json:item></author><articleId><json:string>jeft818922</json:string></articleId><arkIstex>ark:/67375/NVC-7VL246DW-T</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>other</json:string></originalGenre><abstract>Drawing on their experience in producing a Cochrane review of neuraminidase inhibitors for influenza, Tom Jefferson and colleagues discuss how to improve the reliability of systematic reviews</abstract><qualityIndicators><score>5.982</score><pdfWordCount>3658</pdfWordCount><pdfCharCount>23866</pdfCharCount><pdfVersion>1.4</pdfVersion><pdfPageCount>6</pdfPageCount><pdfPageSize>595.276 x 841.89 pts (A4)</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>27</abstractWordCount><abstractCharCount>191</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Ensuring safe and effective drugs: who can do what it takes?</title><pmid><json:string>21224325</json:string></pmid><genre><json:string>other</json:string></genre><host><title>BMJ</title><language><json:string>unknown</json:string></language><issn><json:string>0959-8138</json:string></issn><eissn><json:string>1468-5833</json:string></eissn><publisherId><json:string>bmj</json:string></publisherId><volume>342</volume><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>2009</json:string><json:string>2011</json:string><json:string>2001</json:string><json:string>2006</json:string><json:string>1998</json:string><json:string>1999</json:string><json:string>2008</json:string><json:string>2004</json:string></date><geogName></geogName><orgName><json:string>UK NIHR</json:string><json:string>Department of Family Medicine, Oregon Health and Sciences</json:string><json:string>UK NHS Research and Development fund</json:string><json:string>US Food and Drug</json:string><json:string>Department of Primary Health Care, University of Oxford, Oxford, UK</json:string><json:string>US Oral Neuraminidase Study Group</json:string><json:string>BMJ Publishing Group Ltd</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Hayden F. Impact</json:string><json:string>Cohen D. Complications</json:string><json:string>Are</json:string><json:string>Cohen D. Rosiglitazone</json:string><json:string>Compare</json:string><json:string>Jefferson</json:string><json:string>Van Driel</json:string><json:string>Carl Heneghan</json:string><json:string>S. Rosiglitazone</json:string><json:string>A. Antivirals</json:string><json:string>Peter Doshi</json:string><json:string>The</json:string><json:string>Chris Del</json:string><json:string>Laurent Kaiser</json:string><json:string>K. Effect</json:string><json:string>Tom Jefferson</json:string><json:string>Cochrane</json:string><json:string>La Roche</json:string><json:string>O. Randomized</json:string><json:string>Mark Jones</json:string></persName><placeName><json:string>UK</json:string><json:string>Portland</json:string><json:string>China</json:string><json:string>Japan</json:string><json:string>Basel</json:string><json:string>Italy</json:string><json:string>Oxford</json:string></placeName><ref_url><json:string>http://www.bmj.com/subscribe</json:string><json:string>http://www.bmj.com/permissions</json:string></ref_url><ref_bibl><json:string>Nissen et al</json:string><json:string>Kaiser et al</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/NVC-7VL246DW-T</json:string></ark><categories><wos></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - general & internal medicine</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - General Medicine</json:string></scopus><inist><json:string>1 - sciences humaines et sociales</json:string></inist></categories><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1136/bmj.c7258</json:string></doi><id>575369706032E9792BDE8E219ABA64598CDB13EA</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-7VL246DW-T/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-7VL246DW-T/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/NVC-7VL246DW-T/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a">Ensuring safe and effective drugs: who can do what it takes?</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://publisher-list.data.istex.fr">British Medical Journal Publishing Group</publisher><availability><licence><p>© BMJ Publishing Group Ltd 2011</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</p></availability><date>2011</date></publicationStmt><notesStmt><note type="other" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Ensuring safe and effective drugs: who can do what it takes?</title><author xml:id="author-0000"><persName><forename type="first">Tom</forename><surname>Jefferson</surname></persName><email>pnd@mit.edu</email><note type="biography">researcher</note><note type="correspondence"><p>Correspondence to: P Doshi</p></note><affiliation>researcher</affiliation><affiliation>Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy</affiliation></author><author xml:id="author-0001" corresp="yes"><persName><forename type="first">Peter</forename><surname>Doshi</surname></persName><email>pnd@mit.edu</email><email>pnd@mit.edu</email><note type="biography">doctoral student</note><note type="correspondence"><p>Correspondence to: P Doshi</p></note><affiliation>doctoral student</affiliation><affiliation>Program in History, Anthropology, Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA, USA</affiliation></author><author xml:id="author-0002"><persName><forename type="first">Matthew</forename><surname>Thompson</surname></persName><email>pnd@mit.edu</email><note type="biography">senior clinical scientist</note><note type="correspondence"><p>Correspondence to: P Doshi</p></note><affiliation>senior clinical scientist</affiliation><affiliation>Department of Primary Health Care, University of Oxford, Oxford, UK</affiliation><affiliation>Department of Family Medicine, Oregon Health and Sciences University, Portland, Oregon, USA</affiliation></author><author xml:id="author-0003"><persName><forename type="first">Carl</forename><surname>Heneghan</surname></persName><email>pnd@mit.edu</email><note type="biography">clinical reader and director CEBM</note><note type="correspondence"><p>Correspondence to: P Doshi</p></note><affiliation>clinical reader and director CEBM</affiliation><affiliation>Department of Primary Health Care, University of Oxford, Oxford, UK</affiliation></author><author xml:id="author-0004"><persName><forename type="first">Cochrane Acute Respiratory Infections</forename><surname>Group</surname></persName><email>pnd@mit.edu</email><note type="correspondence"><p>Correspondence to: P Doshi</p></note></author><idno type="istex">575369706032E9792BDE8E219ABA64598CDB13EA</idno><idno type="ark">ark:/67375/NVC-7VL246DW-T</idno><idno type="DOI">10.1136/bmj.c7258</idno><idno type="href">bmj-342-bmj-c7258.pdf</idno><idno type="article-id">jeft818922</idno><idno type="Related-article-href">10.1136/bmj.c7153</idno><idno type="local">bmj;342/jan11_1/c7258</idno></analytic><monogr><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="pISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><idno type="publisher-id">bmj</idno><idno type="PublisherID-hwp">bmj</idno><idno type="PublisherID-nlm-ta">BMJ</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2011"></date><biblScope unit="volume">342</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2011</date></creation><langUsage><language ident="en">en</language></langUsage><abstract style="teaser"><p>Drawing on their experience in producing a Cochrane review of neuraminidase inhibitors for influenza, Tom Jefferson and colleagues discuss how to improve the reliability of systematic reviews</p></abstract></profileDesc><revisionDesc><change when="2011">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-7VL246DW-T/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="other"><front><journal-meta><journal-id journal-id-type="hwp">bmj</journal-id><journal-id journal-id-type="nlm-ta">BMJ</journal-id><journal-id journal-id-type="publisher-id">bmj</journal-id><journal-title>BMJ</journal-title><abbrev-journal-title abbrev-type="publisher">BMJ</abbrev-journal-title><issn pub-type="ppub">0959-8138</issn><issn pub-type="epub">1468-5833</issn><publisher><publisher-name>British Medical Journal Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">jeft818922</article-id><article-id pub-id-type="doi">10.1136/bmj.c7258</article-id><article-id pub-id-type="other">bmj;342/jan11_1/c7258</article-id><article-id pub-id-type="other">bmj;bmj.c7258</article-id><article-id pub-id-type="other">jan11_1</article-id><article-id pub-id-type="other">bmj.c7258</article-id><article-id pub-id-type="other">bmj.c7258</article-id><article-categories><subj-group subj-group-type="heading"><subject>Analysis</subject></subj-group></article-categories><title-group><article-title>Ensuring safe and effective drugs: who can do what it takes?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="no"><name><surname>Jefferson</surname><given-names>Tom</given-names></name><role>researcher</role><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Doshi</surname><given-names>Peter</given-names></name><role>doctoral student</role><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author" corresp="no"><name><surname>Thompson</surname><given-names>Matthew</given-names></name><role>senior clinical scientist</role><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author" corresp="no"><name><surname>Heneghan</surname><given-names>Carl</given-names></name><role>clinical reader and director CEBM</role><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author" corresp="no"><name><surname>Group</surname><given-names>Cochrane Acute Respiratory Infections</given-names></name></contrib><aff id="aff1"><label>1</label>Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy</aff><aff id="aff2"><label>2</label>Program in History, Anthropology, Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA, USA</aff><aff id="aff3"><label>3</label>Department of Primary Health Care, University of Oxford, Oxford, UK</aff><aff id="aff4"><label>4</label>Department of Family Medicine, Oregon Health and Sciences University, Portland, Oregon, USA</aff></contrib-group><author-notes><corresp>Correspondence to: P Doshi <email>pnd@mit.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="ppub"><year>2011</year></pub-date><pub-date pub-type="epub-original"><year>2011</year></pub-date><volume>342</volume><volume-id pub-id-type="other">342</volume-id><volume-id pub-id-type="other">342</volume-id><elocation-id>c7258</elocation-id><history><date date-type="accepted"><day>7</day><month>November</month><year>2010</year></date></history><permissions><copyright-statement>© BMJ Publishing Group Ltd 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>BMJ Publishing Group Ltd</copyright-holder></permissions><self-uri content-type="pdf" xlink:role="full-text" xlink:href="bmj-342-bmj-c7258.pdf"></self-uri><related-article xlink:href="10.1136/bmj.c7153" related-article-type="companion" ext-link-type="doi" xlink:type="simple">Research, doi:10.1136/bmj.c7153</related-article><abstract abstract-type="teaser"><p>Drawing on their experience in producing a Cochrane review of neuraminidase inhibitors for influenza, <bold>Tom Jefferson and colleagues</bold> discuss how to improve the reliability of systematic reviews</p></abstract></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Ensuring safe and effective drugs: who can do what it takes?</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Ensuring safe and effective drugs: who can do what it takes?</title></titleInfo><name type="personal"><namePart type="given">Tom</namePart><namePart type="family">Jefferson</namePart><affiliation>Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy</affiliation><affiliation>E-mail: pnd@mit.edu</affiliation><description>Correspondence to: P Doshi</description><description>researcher</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal" displayLabel="corresp"><namePart type="given">Peter</namePart><namePart type="family">Doshi</namePart><affiliation>Program in History, Anthropology, Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA, USA</affiliation><affiliation>E-mail: pnd@mit.edu</affiliation><affiliation>E-mail: pnd@mit.edu</affiliation><description>Correspondence to: P Doshi</description><description>doctoral student</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Matthew</namePart><namePart type="family">Thompson</namePart><affiliation>Department of Primary Health Care, University of Oxford, Oxford, UK</affiliation><affiliation>Department of Family Medicine, Oregon Health and Sciences University, Portland, Oregon, USA</affiliation><affiliation>E-mail: pnd@mit.edu</affiliation><description>Correspondence to: P Doshi</description><description>senior clinical scientist</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Carl</namePart><namePart type="family">Heneghan</namePart><affiliation>Department of Primary Health Care, University of Oxford, Oxford, UK</affiliation><affiliation>E-mail: pnd@mit.edu</affiliation><description>Correspondence to: P Doshi</description><description>clinical reader and director CEBM</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Cochrane Acute Respiratory Infections</namePart><namePart type="family">Group</namePart><affiliation>E-mail: pnd@mit.edu</affiliation><description>Correspondence to: P Doshi</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="other" displayLabel="other" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-7474895G-0">other</genre><originInfo><publisher>British Medical Journal Publishing Group</publisher><dateIssued encoding="w3cdtf">2011</dateIssued><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><abstract type="teaser">Drawing on their experience in producing a Cochrane review of neuraminidase inhibitors for influenza, Tom Jefferson and colleagues discuss how to improve the reliability of systematic reviews</abstract><relatedItem type="host"><titleInfo><title>BMJ</title></titleInfo><titleInfo type="abbreviated"><title>BMJ</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0959-8138</identifier><identifier type="eISSN">1468-5833</identifier><identifier type="PublisherID">bmj</identifier><identifier type="PublisherID-hwp">bmj</identifier><identifier type="PublisherID-nlm-ta">BMJ</identifier><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>342</number></detail></part></relatedItem><relatedItem type="reviewOf"><identifier type="doi">10.1136/bmj.c7153</identifier></relatedItem><identifier type="istex">575369706032E9792BDE8E219ABA64598CDB13EA</identifier><identifier type="ark">ark:/67375/NVC-7VL246DW-T</identifier><identifier type="DOI">10.1136/bmj.c7258</identifier><identifier type="href">bmj-342-bmj-c7258.pdf</identifier><identifier type="ArticleID">jeft818922</identifier><identifier type="Related-article-href">10.1136/bmj.c7153</identifier><identifier type="local">bmj;342/jan11_1/c7258</identifier><accessCondition type="use and reproduction" contentType="copyright">© BMJ Publishing Group Ltd 2011</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</recordContentSource><recordOrigin>© BMJ Publishing Group Ltd 2011</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-7VL246DW-T/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F70 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001F70 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:575369706032E9792BDE8E219ABA64598CDB13EA
|texte= Ensuring safe and effective drugs: who can do what it takes?
}}
| This area was generated with Dilib version V0.6.34. |  |